Effectiveness of Homologous and Heterologous COVID-19 Booster Doses Following 1 Ad.26.COV2.S (Janssen [Johnson & Johnson]) Vaccine Dose Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults - VISION Network, 10 States, December 2021-March 2022

Natarajan, Karthik ; Prasad, Namrata ; Dascomb, Kristin ; Irving, Stephanie A ; Yang, Duck-Hye ; Gaglani, Manjusha ; Klein, Nicola P ; DeSilva, Malini B ; Ong, Toan C ; Grannis, Shaun J ; Stenehjem, Edward ; Link-Gelles, Ruth ; Rowley, Elizabeth A ; Naleway, Allison L ; Han, Jungmi ; Raiyani, Chandni ; Benitez, Gabriela Vazquez ; Rao, Suchitra ; Lewis, Ned ; Fadel, William F ; Grisel, Nancy ; Griggs, Eric P ; Dunne, Margaret M ; Stockwell, Melissa S ; Mamawala, Mufaddal ; McEvoy, Charlene ; Barron, Michelle A ; Goddard, Kristin ; Valvi, Nimish R ; Arndorfer, Julie ; Patel, Palak ; Mitchell, Patrick K ; Smith, Michael ; Kharbanda, Anupam B ; Fireman, Bruce ; Embi, Peter J ; Dickerson, Monica ; Davis, Jonathan M ; Zerbo, Ousseny ; Dalton, Alexandra F ; Wondimu, Mehiret H ; Azziz-Baumgartner, Eduardo ; Bozio, Catherine H ; Reynolds, Sue ; Ferdinands, Jill ; Williams, Jeremiah ; Schrag, Stephanie J ; Verani, Jennifer R ; Ball, Sarah ; Thompson, Mark G ; Dixon, Brian E

MMWR. Morbidity and mortality weekly report, 2022-04, Vol.71 (13), p.495-502

United States: U.S. Government Printing Office

Texto completo disponível